Stay updated on Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision tag in the page footer updated from v3.5.3 to v3.5.4, indicating a minor site version update rather than changes to the study record.
    Difference
    0.1%
    Check dated 2026-05-15T05:55:27.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Latest revision in the Study Record History is now Revision: v3.5.3, replacing Revision: v3.5.2. This update records a new metadata version for the record rather than altering substantive study details.
    Difference
    0.1%
    Check dated 2026-04-30T18:41:10.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new UI revision entry, v3.5.2, was added to the Record History and an older revision, v3.5.0, was removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:11:27.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T20:23:37.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed in the record history. This appears to be a minor maintenance update to the page history rather than a change to trial details.
    Difference
    0.1%
    Check dated 2026-03-11T20:00:24.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Added site revision v3.4.2 and removed the funding-lapse notice and the previous revision v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T02:34:09.000Z thumbnail image

Stay in the know with updates to Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.